Is a complete NSE/MEDANTA research report available?

Question

Accepted Answer

No complete published report is available for nse/MEDANTA (NSE/MEDANTA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Volume
Market cap	385.3B
Revenue (ttm)	44.1B
Net income (ttm)	5.6B
EPS (ttm)	₹20.7
Shares out	268.9M
P/E (trailing)	69.4x
P/E (forward)	55.4x
Dividend	₹0.50 (0.04%)

Metric	Value
Country	India
Country code	IN
Employees	10,260
Employees Change	1,208%
Employees Change Percent	13.35
Enterprise value	INR 386.1B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical Care Facilities
Industry PE	67.37
Industry PE Fwd	46.19
Isin	INE474Q01031
Last refreshed	2026-07-30
Market cap	INR 385.3B
Price	INR 1,435
Price currency	INR
Rev Per Employee	4,298,504.87x
Sector	Healthcare
Sector PE	46.52
Sector PE Fwd	37.94
Sic	8060
Symbol	nse/MEDANTA
Website	https://www.medanta.org

Metric	Value
Earnings Yield	1.44%
EV Earnings	69.38x
EV/EBIT	55.43x
EV/EBITDA	42.01x
EV/Sales	8.75x
FCF yield	-0.32%
Forward P/E	55.4x
P/B ratio	9.67x
P/E ratio	69.36x
P/S ratio	8.74x
PE Ratio3 Y	58.97x
PE Ratio5 Y	57.34x
PEG ratio	2.82x

Metric	Value
EBIT Margin	15.79%
EBITDA Margin	20.84%
Gross margin	52.54%
Gross Profit	INR 23.2B
Gross Profit Growth	21%
Gross Profit Growth Q	42.48%
Gross Profit Growth3 Y	18.99%
Net Income	INR 5.6B
Net Income Growth	15.58%
Net Income Growth Q	42%
Net Income Growth Quarters	1%
Net Income Growth Years	5%
Net Income Growth3 Y	19.5%
Pretax Margin	16.21%
Profit Margin	12.62%
Profit Per Employee	INR 542,359
Profitable Quarters	INR 19
Profitable Years	9
ROA	8.16
Roa5y	8.48
ROCE	13.2
ROE	15.03
Roe5y	15.49
ROIC	14.43
Roic5y	15.91

Metric	Value
Cagr1y	5.92%
Cagr3y	26.81%
EPS Growth	15.29
EPS Growth Q	42.04
EPS Growth Quarters	1
EPS Growth Years	5
EPS Growth3 Y	18.01
OCF Growth	14.53%
OCF Growth3 Y	3.49%
Revenue Growth	19.44x
Revenue Growth Q	24.46x
Revenue Growth Quarters	15x
Revenue Growth Years	5x
Revenue Growth3 Y	17.63x

NSE/MEDANTA (NSE/MEDANTA)

Coverage state: Market snapshot only — no published research

Generate the first NSE/MEDANTA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · NSE/MEDANTA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/MEDANTA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NSE/MEDANTA

Frequently asked questions

Metric	Value
Asset Turnover	INR 0.83
Assets	INR 59.1B
Cash	INR 11.3B
Current Assets	INR 16.7B
Current Liabilities	INR 6.3B
Debt	INR 11.9B
Debt EBITDA	INR 1.29
Debt Equity	INR 0.3
Debt FCF	INR -9.61
Equity	INR 39.8B
Interest Coverage	8.8
Liabilities	INR 19.2B
Long Term Assets	INR 42.3B
Long Term Liabilities	INR 12.9B
Net Cash	INR -598.2M
Net Cash By Market Cap	INR -0.16
Net Debt EBITDA	INR 0.07
Net Debt Equity	INR 0.02
Tangible Book Value	INR 39.5B
Tangible Book Value Per Share	INR 147
WACC	5.14

Metric	Value
Current ratio	2.67
Inventory Turnover	28.65
Net Working Capital	INR -194.5M
Quick ratio	2.46
Working Capital	INR 10.5B
Working Capital Turnover	INR 4.5

Metric	Value
Buyback Yield	-0.27%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 0.5
Dividend Years	1
Dividend Yield	0.04%
Last Dividend	INR 0.5
Payout Ratio	2.42%

Metric	Value
1Y total return	5.91%
200-day SMA	1,197.7
3Y total return	103.94%
50-day SMA	1,288.7
50-day SMA vs 200-day SMA	50over200
All Time High	1,513.9
All Time High Change	-5.21%
All Time High Date	2024-02-16
All Time Low	390.6
All Time Low Change	267.43%
All Time Low Date	2022-11-16
ATR	35.1
Beta	0.16
Beta1y	0.17
Beta2y	0.16
Ch YTD	20.95
High	1,438
High52	1,456.5
High52 Date	2025-08-08
High52ch	-1.48%
Low	1,394.3
Low52	956
Low52 Date	2026-03-30
Low52ch	50.11%
Ma50ch	11.35%
Price vs 200-day SMA	19.82%
RSI	72.7
RSI Monthly	63.55
RSI Weekly	68.81
Sharpe ratio	0.34x
Sortino ratio	0.72
Total Return	-0.24%
Tr YTD	20.95
Tr1m	9.34%
Tr1w	6.88%
Tr3m	26.15%

Metric	Value
Analyst Count	17
Analyst Ratings	Strong Buy
Operating Income	INR 7B
Operating Income Growth	1.99
Operating Income Growth Q	1.25
Operating Income Growth3 Y	12.87
Operating margin	15.79
Price target	INR 1,439
Price Target Change	INR 0.28

Metric	Value
Float	88,513,848%
Net Borrowing	3,435,040,000
Shares Insiders	43.79%
Shares Institutions	22.9%
Shares Out	268,871,782
Shares Qo Q	0.27%
Shares Yo Y	0.27%

Metric	Value
Adjusted FCF	INR -1.6B
Adjusted OCF	6,760,930,000
Average Volume	190,130.15x
Bv Per Share	147.5
CAPEX	INR -8.4B
Ch1m	9.34
Ch1w	6.88
Ch1y	5.87
Ch3m	26.15
Ch3y	103.9
Ch6m	36.8
Change	2.4%
Change From Open	2.91
Close	1,401.3
Days Gap	-0.49
Depreciation Amortization	2,225,400,000
Dollar Volume	352,731,610
Earnings Date	2026-07-30
EBIT	INR 7B
EBITDA	INR 9.2B
EPS	INR 20.66
F Score	7
FCF	INR -1.2B
FCF EV Yield	-0.32x
FCF Per Share	INR -4.6
Financing CF	2,718,530,000
Fiscal Year End	March
Founded	2,004
Graham Number	261.82393
Graham Upside	-81.75
Income Tax	INR 1.6B
Investing CF	-10,891,110,000
Is Primary Listing	1
Last Earnings Date	2026-07-30
Last Report Date	2026-03-31
Lynch Fair Value	INR 403
Lynch Upside	-71.92
Ma150	1,176.5
Ma150ch	21.97%
Ma20	1,350.8
Ma20ch	6.23%
Net CF	-1,028,670,000
Next Earnings Date	2026-07-30
Open	1,394.4
P OCF Ratio	53.93
P OCF Ratio SBC	56.98
Payment Date	2025-10-18
Position In Range	93.14
Ppne	39,109,190,000
Price Date	2026-07-29
Price EBITDA	INR 41.92
Ptbv Ratio	9.77
Relative Volume	1.37x
Revenue	44,102,660,000x
SBC By Revenue	0.87x
Share Based Comp	382,980,000
Tax By Revenue	3.65x
Tax Rate	22.51%
Tr6m	36.8%
Volume	245,806